Cite
Di Guardo L, Randon G, Corti F, et al. Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with BRAF Mutated Melanoma. Oncologist. 2021;26(12):1079-1084doi: 10.1002/onco.13926.
Di Guardo, L., Randon, G., Corti, F., Vallacchi, V., Raimondi, A., Fucà, G., Bini, M., Maurichi, A., Patuzzo, R., Gallino, G., Mattavelli, I., Ruggeri, R., Angi, M., Cossa, M., Valeri, B., Cimminiello, C., Santinami, M., Rivoltini, L., de Braud, F., Rodolfo, M., & Vecchio, M. D. (2021). Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with BRAF Mutated Melanoma. The oncologist, 26(12), 1079-1084. https://doi.org/10.1002/onco.13926
Di Guardo, Lorenza, et al. "Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with BRAF Mutated Melanoma." The oncologist vol. 26,12 (2021): 1079-1084. doi: https://doi.org/10.1002/onco.13926
Di Guardo L, Randon G, Corti F, Vallacchi V, Raimondi A, Fucà G, Bini M, Maurichi A, Patuzzo R, Gallino G, Mattavelli I, Ruggeri R, Angi M, Cossa M, Valeri B, Cimminiello C, Santinami M, Rivoltini L, de Braud F, Rodolfo M, Vecchio MD. Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with BRAF Mutated Melanoma. Oncologist. 2021 Dec;26(12):1079-1084. doi: 10.1002/onco.13926. Epub 2021 Sep 21. PMID: 34355463.
Copy
Download .nbib